TC BioPharm(TCBP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TCBP TC BioPharm

盘后交易 11-15 19:22:12 EST

0.6620

+0.0132

+2.03%

盘后0.6214

-0.0406-6.13%

19:13 EST

最高0.9599	最低0.5574	成交量2,762万
今开0.7801	昨收0.6488	日振幅62.03%
总市值34.32万	流通市值34.32万	总股本51.85万
成交额2,142万	换手率5,327.35%	流通股本51.85万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"TCBP","market":"US","secType":"STK","nameCN":"TC BioPharm","latestPrice":0.662,"timestamp":1731704400000,"preClose":0.648839,"halted":0,"volume":27622317,"hourTrading":{"tag":"盘后","latestPrice":0.6214,"preClose":0.662,"latestTime":"19:13 EST","volume":58367,"amount":36056.338571709995,"timestamp":1731716031783},"delay":0,"floatShares":518500,"shares":518500,"eps":-164.45044,"marketStatus":"盘后交易","marketStatusCode":4,"change":0.013161,"latestTime":"11-15 19:22:12 EST","open":0.7801,"high":0.9599,"low":0.5574,"amount":21416266.298668917,"amplitude":0.620339,"askPrice":0.6816,"askSize":100,"bidPrice":0.602,"bidSize":10,"shortable":0,"etf":0,"ttmEps":-164.45044,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1731718800000},"adr":0,"listingDate":1644555600000,"adjPreClose":0.648839,"adrRate":200,"preHourTrading":{"tag":"盘前","latestPrice":0.761,"preClose":0.641,"latestTime":"09:29 EST","volume":4074564,"amount":4474868.7252672,"timestamp":1731680973927},"postHourTrading":{"tag":"盘后","latestPrice":0.6214,"preClose":0.662,"latestTime":"19:13 EST","volume":58367,"amount":36056.338571709995,"timestamp":1731716031783},"volumeRatio":36.625872},"requestUrl":"/m/hq/s/TCBP","defaultTab":"news","newsList":[{"id":"2483377141","title":"Tc Biopharm (Holdings) Plc股价飙升17.29% 市值涨7.52万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483377141","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483377141?lang=zh_cn&edition=full","pubTime":"2024-11-15 22:31","pubTimestamp":1731681085,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日22时31分，Tc Biopharm  Plc股票出现异动，股价急速拉升17.29%。Tc Biopharm  Plc股票所在的生物技术行业中，整体跌幅为0.69%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111522312595be340a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111522312595be340a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TCBP"],"gpt_icon":0},{"id":"2483884323","title":"Tc Biopharm (Holdings) Plc盘中异动 早盘急速下跌5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483884323","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483884323?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:38","pubTimestamp":1731508688,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时38分，Tc Biopharm  Plc股票出现波动，股价大幅下跌5.31%。Tc Biopharm  Plc股票所在的生物技术行业中，整体涨幅为0.16%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113223808abbde0ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113223808abbde0ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCBP","BK4139"],"gpt_icon":0},{"id":"2482573872","title":"Tc Biopharm (Holdings) Plc盘中异动 快速下挫5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482573872","media":"市场透视","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482573872?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:40","pubTimestamp":1731336010,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时40分，Tc Biopharm  Plc股票出现波动，股价快速下挫5.26%。Tc Biopharm  Plc股票所在的生物技术行业中，整体跌幅为0.09%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111224010abb666bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111224010abb666bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TCBP"],"gpt_icon":0},{"id":"2481184900","title":"Tc Biopharm (Holdings) Plc盘中异动 急速拉升5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481184900","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481184900?lang=zh_cn&edition=full","pubTime":"2024-11-07 23:11","pubTimestamp":1730992297,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日23时11分，Tc Biopharm  Plc股票出现异动，股价大幅拉升5.26%。Tc Biopharm  Plc股票所在的生物技术行业中，整体涨幅为0.10%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110723113798e413a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110723113798e413a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCBP","BK4139"],"gpt_icon":0},{"id":"2481198504","title":"Tc Biopharm (Holdings) Plc盘中异动 早盘股价大跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481198504","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481198504?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:50","pubTimestamp":1730904639,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时50分，Tc Biopharm  Plc股票出现波动，股价大幅跳水5.19%。Tc Biopharm  Plc股票所在的生物技术行业中，整体跌幅为0.94%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622504098e40e81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622504098e40e81&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCBP","BK4139"],"gpt_icon":0},{"id":"2481653692","title":"Tc Biopharm (Holdings) Plc盘中异动 快速拉升5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481653692","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481653692?lang=zh_cn&edition=full","pubTime":"2024-11-05 00:31","pubTimestamp":1730737866,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日00时31分，Tc Biopharm  Plc股票出现异动，股价急速上涨5.34%。Tc Biopharm  Plc股票所在的生物技术行业中，整体涨幅为0.33%。其相关个股中，Neurogene Inc.、Tenaya Therapeutics, Inc.、Disc Medicine, Inc.涨幅较大，Elevai Labs, Inc.、Nls Pharmaceutics Ltd.、Gri Bio, Inc.较为活跃，换手率分别为320.58%、271.82%、73.11%，振幅较大的相关个股有Sab Biotherapeutics Inc C/Wts 22/10/2026 、In8Bio, Inc.、Kazia Therapeutics Limited，振幅分别为52.25%、45.39%、39.13%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110500310698e4052d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110500310698e4052d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TCBP"],"gpt_icon":0},{"id":"2480852684","title":"Tc Biopharm (Holdings) Plc盘中异动 临近收盘股价大跌5.30%报1.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480852684","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480852684?lang=zh_cn&edition=full","pubTime":"2024-11-02 03:58","pubTimestamp":1730491086,"startTime":"0","endTime":"0","summary":"北京时间2024年11月02日03时58分，Tc Biopharm  Plc股票出现异动，股价快速下挫5.30%。Tc Biopharm  Plc股票所在的生物技术行业中，整体涨幅为0.48%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241102035806a20b0c23&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241102035806a20b0c23&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TCBP"],"gpt_icon":0},{"id":"2479035522","title":"Tc Biopharm (Holdings) Plc盘中异动 早盘股价大跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479035522","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479035522?lang=zh_cn&edition=full","pubTime":"2024-10-31 22:01","pubTimestamp":1730383279,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日22时01分，Tc Biopharm  Plc股票出现异动，股价大幅下挫5.26%。Tc Biopharm  Plc股票所在的生物技术行业中，整体跌幅为2.42%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031220119a2023e25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031220119a2023e25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TCBP"],"gpt_icon":0},{"id":"2479499786","title":"Tc Biopharm (Holdings) Plc盘中异动 股价大跌5.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479499786","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479499786?lang=zh_cn&edition=full","pubTime":"2024-10-30 21:53","pubTimestamp":1730296405,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日21时53分，Tc Biopharm  Plc股票出现异动，股价急速下跌5.55%。Tc Biopharm  Plc股票所在的生物技术行业中，整体跌幅为0.32%。其相关个股中，Tharimmune, Inc.、Ensysce Biosciences, Inc.、Quince Therapeutics, Inc.涨幅较大，Tharimmune, Inc.、Ensysce Biosciences, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为2954.86%、475.73%、32.97%，振幅较大的相关个股有Tharimmune, Inc.、Ensysce Biosciences, Inc.、Quince Therapeutics, Inc.，振幅分别为70.94%、52.36%、34.92%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021532598e3f6ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021532598e3f6ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCBP","BK4139"],"gpt_icon":0},{"id":"2479283692","title":"Tc Biopharm (Holdings) Plc盘中异动 快速下跌5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479283692","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479283692?lang=zh_cn&edition=full","pubTime":"2024-10-29 21:36","pubTimestamp":1730208974,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日21时36分，Tc Biopharm  Plc股票出现异动，股价快速下跌5.18%。Tc Biopharm  Plc股票所在的生物技术行业中，整体涨幅为0.09%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029213614971a2ecb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029213614971a2ecb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TCBP"],"gpt_icon":0},{"id":"2478948948","title":"Tc Biopharm (Holdings) Plc盘中异动 股价大涨6.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478948948","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478948948?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:31","pubTimestamp":1730122305,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时31分，Tc Biopharm  Plc股票出现异动，股价大幅拉升6.25%。Tc Biopharm  Plc股票所在的生物技术行业中，整体涨幅为0.25%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102821314695bd7513&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102821314695bd7513&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCBP","BK4139"],"gpt_icon":0},{"id":"2478893345","title":"Tc Biopharm (Holdings) Plc盘中异动 早盘快速下挫5.04%报1.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478893345","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478893345?lang=zh_cn&edition=full","pubTime":"2024-10-25 21:41","pubTimestamp":1729863708,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日21时41分，Tc Biopharm  Plc股票出现异动，股价快速下挫5.04%。Tc Biopharm  Plc股票所在的生物技术行业中，整体涨幅为0.74%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025214148971a2539&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025214148971a2539&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCBP","ELAB","BK4183","BK4139"],"gpt_icon":0},{"id":"2477533594","title":"Tc Biopharm (Holdings) Plc盘中异动 快速下挫6.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477533594","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477533594?lang=zh_cn&edition=full","pubTime":"2024-10-23 21:35","pubTimestamp":1729690514,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日21时35分，Tc Biopharm  Plc股票出现异动，股价快速下跌6.90%。Tc Biopharm  Plc股票所在的生物技术行业中，整体跌幅为0.32%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102321351498e3dfdd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102321351498e3dfdd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TCBP"],"gpt_icon":0},{"id":"2477086180","title":"Tc Biopharm (Holdings) Plc盘中异动 早盘急速跳水5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477086180","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477086180?lang=zh_cn&edition=full","pubTime":"2024-10-21 22:28","pubTimestamp":1729520939,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日22时28分，Tc Biopharm  Plc股票出现异动，股价急速跳水5.53%。Tc Biopharm  Plc股票所在的生物技术行业中，整体跌幅为0.53%。其相关个股中，Genprex, Inc.、Biovie Inc.、Gri Bio, Inc.涨幅较大，Genprex, Inc.、Gri Bio, Inc.、Biovie Inc.较为活跃，换手率分别为3774.93%、2496.98%、975.06%，振幅较大的相关个股有Genprex, Inc.、Biovie Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 ，振幅分别为226.88%、157.02%、116.08%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021222859971a1659&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021222859971a1659&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCBP","BK4139"],"gpt_icon":0},{"id":"2474229229","title":"Tc Biopharm (Holdings) Plc盘中异动 股价大跌5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474229229","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474229229?lang=zh_cn&edition=full","pubTime":"2024-10-09 21:51","pubTimestamp":1728481911,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日21时51分，Tc Biopharm  Plc股票出现异动，股价急速下挫5.88%。Tc Biopharm  Plc股票所在的生物技术行业中，整体跌幅为0.55%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Inhibikase Therapeutics, Inc.、Gri Bio, Inc.涨幅较大，Windtree Therapeutics, Inc.、Aditxt, Inc.、Inhibikase Therapeutics, Inc.较为活跃，换手率分别为642.85%、177.75%、72.50%，振幅较大的相关个股有Cue Biopharma, Inc.、Inhibikase Therapeutics, Inc.、Sonnet Biotherapeutics Holdings, Inc.，振幅分别为39.02%、24.37%、19.67%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009215151a1df6be3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009215151a1df6be3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKT","TCBP","BK4139"],"gpt_icon":0},{"id":"2473105328","title":"Tc Biopharm (Holdings) Plc盘中异动 急速拉升7.11%报8.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473105328","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473105328?lang=zh_cn&edition=full","pubTime":"2024-10-07 21:31","pubTimestamp":1728307918,"startTime":"0","endTime":"0","summary":"北京时间2024年10月07日21时31分，Tc Biopharm  Plc股票出现波动，股价急速拉升7.11%。Tc Biopharm  Plc股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Scholar Rock Holding Corporation、Ibio, Inc.、Humacyte Inc C/Wts 27/08/2026 涨幅较大，Aditxt, Inc.、Phio Pharmaceuticals Corp.、Elevai Labs, Inc.较为活跃，换手率分别为530.59%、47.72%、9.90%，振幅较大的相关个股有Scholar Rock Holding Corporation、Renovaro Inc.、Nkgen Biotech, Inc.，振幅分别为31.67%、9.50%、9.13%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241007213159ab681a6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241007213159ab681a6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCBP","BK4139"],"gpt_icon":0},{"id":"2472619517","title":"Tc Biopharm (Holdings) Plc盘中异动 早盘股价大涨8.74%报6.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472619517","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472619517?lang=zh_cn&edition=full","pubTime":"2024-10-03 22:01","pubTimestamp":1727964065,"startTime":"0","endTime":"0","summary":"北京时间2024年10月03日22时01分，Tc Biopharm  Plc股票出现异动，股价急速拉升8.74%。Tc Biopharm  Plc股票所在的生物技术行业中，整体跌幅为0.56%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241003220105a1de2672&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241003220105a1de2672&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TCBP","ELAB","BK4183"],"gpt_icon":0},{"id":"2472526097","title":"Tc Biopharm (Holdings) Plc盘中异动 急速上涨7.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472526097","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472526097?lang=zh_cn&edition=full","pubTime":"2024-10-02 21:34","pubTimestamp":1727876075,"startTime":"0","endTime":"0","summary":"北京时间2024年10月02日21时34分，Tc Biopharm  Plc股票出现异动，股价快速拉升7.49%。Tc Biopharm  Plc股票所在的生物技术行业中，整体跌幅为1.14%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100221343598e3a338&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100221343598e3a338&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TCBP"],"gpt_icon":0},{"id":"2472339778","title":"Tc Biopharm (Holdings) Plc盘中异动 大幅下跌6.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472339778","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472339778?lang=zh_cn&edition=full","pubTime":"2024-10-01 01:00","pubTimestamp":1727715647,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日01时00分，Tc Biopharm  Plc股票出现异动，股价快速下跌6.13%。Tc Biopharm  Plc股票所在的生物技术行业中，整体涨幅为0.10%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410010100479719da40&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410010100479719da40&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCBP","BK4139"],"gpt_icon":0},{"id":"2470003178","title":"Tc Biopharm (Holdings) Plc盘中异动 快速下跌6.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470003178","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470003178?lang=zh_cn&edition=full","pubTime":"2024-09-28 00:47","pubTimestamp":1727455679,"startTime":"0","endTime":"0","summary":"北京时间2024年09月28日00时47分，Tc Biopharm  Plc股票出现波动，股价大幅跳水6.30%。Tc Biopharm  Plc股票所在的生物技术行业中，整体跌幅为0.90%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240928004800ab66897a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240928004800ab66897a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCBP","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tcbiopharm.com","stockEarnings":[{"period":"1week","weight":-0.4407},{"period":"1month","weight":-0.8725},{"period":"3month","weight":-0.831},{"period":"6month","weight":-0.9426},{"period":"1year","weight":-0.9937},{"period":"ytd","weight":-0.9795}],"compareEarnings":[{"period":"1week","weight":-0.0038},{"period":"1month","weight":0.0234},{"period":"3month","weight":0.0704},{"period":"6month","weight":0.1207},{"period":"1year","weight":0.3195},{"period":"ytd","weight":0.2483}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"TC BioPharm (Holdings) plc.是一家于2021年10月25日根据苏格兰法律注册成立的公司。TC BioPharm 是一家临床阶段的生物制药公司，专注于基于其专有的同种异体gamma delta T (GD-T)细胞平台开发新型免疫治疗产品。利用GD-T的先天能力，TCB能够开发一系列旨在对抗癌症和病毒感染的临床阶段细胞疗法。","exchange":"NASDAQ","name":"TC BioPharm","nameEN":"TC BioPharm"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TC BioPharm(TCBP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供TC BioPharm(TCBP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"TC BioPharm,TCBP,TC BioPharm股票,TC BioPharm股票老虎,TC BioPharm股票老虎国际,TC BioPharm行情,TC BioPharm股票行情,TC BioPharm股价,TC BioPharm股市,TC BioPharm股票价格,TC BioPharm股票交易,TC BioPharm股票购买,TC BioPharm股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TC BioPharm(TCBP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供TC BioPharm(TCBP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}